SAHPRA update on Section 21 authorisation for Pfizer Comirnaty Vaccine
10 September 2021 The South African Health Products Authority (SAHPRA) has approved the use of the P...
10 September, 21
News & Updates
-
-
FDA’s stance on ivermectin aligned to SAHPRA’s position
3 September 2021 The South African Health Products Regulatory Authority (SAHPRA) is aligned with the...
03 September, 21 -
SAHPRA’s vaccine registration process and role of the SAHPRA Board
30 July 2021 The South African Health Products Regulatory Authority (SAHPRA) is an independent, scie...
30 August, 21 -
SAHPRA Statement on Adverse Events Following Immunisation (AEFIs) with COVID 19 VaccineS
20 August 2021 The South African Health Products Regulatory Authority (SAHPRA) has a mandate to over...
20 August, 21
SAHPRA TV and Podcasts
Stay up to date with our latest news, media coverages, interviews and announcements on SAHPRA TV.
Safety alerts
-
Risk of Drug-Induced Liver Injury associated with the use of Esbriet®
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20 -
MSA DIPHENHYDRAMINE-CONTAINING MEDICINES
SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma ...
01 November, 20 -
THE METFORMIN-CONTAINING MEDICINES THAT ARE REGISTERED AND IN PROCESS
The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulat...
12 October, 20 -
THE RANITIDINE-CONTAINING MEDICINES THAT ARE REGISTERED AND IN PROCESS
The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulat...
12 October, 20
The Med Safety App
SAHPRA’s new Medsafety mobile reporting app, makes it easy to report adverse effects to medicines, including vaccines.
PRODUCT RECALLS
Procter & Gamble South African Trading (Pty) Ltd, in consultation with the Medicines Control Council, wishes to alert the public that a small amount…
10 February 2017
This recall is initiated as a result of product quality complaint logged with Aspen Pharmacare due to the discloration of Lethyl 30 mg tablets…
31 July 2015
Following a customer complaint, we have identified the vitamin premix used in the manufacture of the affected product and batches contain additional vitamins and minerals…
Publications
The information on this page is for SAHPRA stakeholders, medical experts and members of the general public.
The annual report has been prepared in accordance with the guidelines on the annual report as issued by the National Treasury.
SOCIAL MEDIA FEEDS
Applicants are treated fairly and consistently. SAHPRA staff members and experts in the scientific community are involved in the vaccine approval process